loading page

COVID 19 infection as a cause of COPD exacerbation in a vaccinated patient
  • +1
  • Sladjana Radosavljevic,
  • Ilija Andrijevic,
  • Jovan Matijasevic,
  • Marija Vukoja
Sladjana Radosavljevic
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia

Corresponding Author:[email protected]

Author Profile
Ilija Andrijevic
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Author Profile
Jovan Matijasevic
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Author Profile
Marija Vukoja
Institute for Pulmonary Diseases of Vojvodina, Put Dr Goldmana 4, Sremska Kamenica, 21204, Serbia
Author Profile

Abstract

According to a largest systematic review, COPD is a significant risk factor for hospitalization, ICU admission and mortality in patients with COVID-19. According to British Thoracic Society patients with severe COPD are considered Clinically Extremely Vulnerable and should receive COVID-19 vaccine. Pfizer's vaccine showed significant effectiveness against COVID-19. In our case patient had severe form of COPD exacerbation after vaccination, which required hospitalization and the non-invasive ventilation but without intubation and radiology verified pneumonia.